Menta Capital’s AbbVie ABBV Stock Holding History

Menta Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-10,400	Closed	-$430K	–	353
2013 Q2	$430K	Buy	+10,400	New	+$455K	0.28%	129

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Menta Capital's ABBV Position: Q3 2013 in Review

Menta Capital sold out of AbbVie (ABBV) in Q3 2013, closing a stake of 10,400 shares — an estimated $430K sold.

Menta Capital first reported a position in ABBV in Q2 2013 and held it in 1 quarter. The position peaked at $430K in Q2 2013. 1,296 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

Menta Capital reported no remaining AbbVie position as of Q3 2013 after selling out during the quarter.
Menta Capital sold 10,400 AbbVie shares in Q3 2013, an estimated $430K.
Menta Capital first reported a position in AbbVie in Q2 2013 and held it in 1 quarter.
Menta Capital's AbbVie position peaked at $430K in Q2 2013.
1,296 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Menta Capital's 13F filing for Q3 2013, filed 5 Nov 2013.